Development and evaluation of a consumer information resource, including Patient Decision Aid, for lung cancer screening : a quasi-experimental study
© Society of Behavioral Medicine 2019. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com..
Lung cancer screening of high-risk individuals with computed tomography is a promising intervention to reduce lung cancer mortality. Patient Decision Aids (PtDAs) may assist eligible individuals assess the risks and benefits associated with screening. Screening preference is high among lower-risk, screening-ineligible individuals and strategies are needed to reduce screening demand among this group. We developed and evaluated a resource comprising a recruitment pamphlet combined with either a PtDA for screening-eligible individuals or an education pamphlet for screening-ineligible individuals. Quasi-experimental pre-post pamphlet exposure design. Ever-smokers aged 55-80 years attending hospital outpatient clinics were invited. Among screening-eligible participants, the assessed outcome was change in score on the Decisional Conflict Scale (DCS). Among screening-ineligible participants, the assessed outcomes were change in screening preference. In the study 51% (55/107) of invited individuals participated, with mean ± standard deviation age 66.9 ± 6.4 years, 53% (29/55) male, and 65% (36/55) eligible for screening. Median (interquartile range) DCS among screening-eligible participants reduced from 28.9 (22.7-45.3) pre-PtDA to 25 (1.6-29.7) post-PtDA (p < .001), but there was no significant change in the proportion that reached the accepted threshold for decisional certainty (DCS < 25, 10/36 [28%] pre-exposure vs. 14/36 [39%] post-exposure, p = .1). Screening preference among screening-ineligible individuals reduced after viewing the screening-ineligible brochure (pre-exposure median of "Prefer" to post-exposure median of "Unsure," p = .001). Our consumer information pamphlets about lung cancer screening may reduce decisional conflict and improve alignment of screening preference with eligibility.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
Translational behavioral medicine - 10(2020), 2 vom: 20. Mai, Seite 404-412 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Manners, David [VerfasserIn] |
---|
Links: |
---|
Themen: |
Journal Article |
---|
Anmerkungen: |
Date Completed 20.07.2021 Date Revised 20.07.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.1093/tbm/ibz029 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM294788050 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM294788050 | ||
003 | DE-627 | ||
005 | 20231225082238.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/tbm/ibz029 |2 doi | |
028 | 5 | 2 | |a pubmed24n0982.xml |
035 | |a (DE-627)NLM294788050 | ||
035 | |a (NLM)30855087 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Manners, David |e verfasserin |4 aut | |
245 | 1 | 0 | |a Development and evaluation of a consumer information resource, including Patient Decision Aid, for lung cancer screening |b a quasi-experimental study |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.07.2021 | ||
500 | |a Date Revised 20.07.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © Society of Behavioral Medicine 2019. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com. | ||
520 | |a Lung cancer screening of high-risk individuals with computed tomography is a promising intervention to reduce lung cancer mortality. Patient Decision Aids (PtDAs) may assist eligible individuals assess the risks and benefits associated with screening. Screening preference is high among lower-risk, screening-ineligible individuals and strategies are needed to reduce screening demand among this group. We developed and evaluated a resource comprising a recruitment pamphlet combined with either a PtDA for screening-eligible individuals or an education pamphlet for screening-ineligible individuals. Quasi-experimental pre-post pamphlet exposure design. Ever-smokers aged 55-80 years attending hospital outpatient clinics were invited. Among screening-eligible participants, the assessed outcome was change in score on the Decisional Conflict Scale (DCS). Among screening-ineligible participants, the assessed outcomes were change in screening preference. In the study 51% (55/107) of invited individuals participated, with mean ± standard deviation age 66.9 ± 6.4 years, 53% (29/55) male, and 65% (36/55) eligible for screening. Median (interquartile range) DCS among screening-eligible participants reduced from 28.9 (22.7-45.3) pre-PtDA to 25 (1.6-29.7) post-PtDA (p < .001), but there was no significant change in the proportion that reached the accepted threshold for decisional certainty (DCS < 25, 10/36 [28%] pre-exposure vs. 14/36 [39%] post-exposure, p = .1). Screening preference among screening-ineligible individuals reduced after viewing the screening-ineligible brochure (pre-exposure median of "Prefer" to post-exposure median of "Unsure," p = .001). Our consumer information pamphlets about lung cancer screening may reduce decisional conflict and improve alignment of screening preference with eligibility | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Lung neoplasms | |
650 | 4 | |a Mass screening | |
650 | 4 | |a Patient preference | |
650 | 4 | |a Shared-decision making | |
650 | 4 | |a X-ray computed tomography | |
700 | 1 | |a Pettigrew, Simone |e verfasserin |4 aut | |
700 | 1 | |a Lake, Fiona R |e verfasserin |4 aut | |
700 | 1 | |a Piccolo, Francesco |e verfasserin |4 aut | |
700 | 1 | |a McWilliams, Annette M |e verfasserin |4 aut | |
700 | 1 | |a Brims, Fraser J H |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Translational behavioral medicine |d 2011 |g 10(2020), 2 vom: 20. Mai, Seite 404-412 |w (DE-627)NLM207693765 |x 1613-9860 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2020 |g number:2 |g day:20 |g month:05 |g pages:404-412 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/tbm/ibz029 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 10 |j 2020 |e 2 |b 20 |c 05 |h 404-412 |